Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Yangilik qisqacha mazmuni
Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.
Ishonchli nashriyotlarning so‘nggi xabarlarini qisqa izohlar bilan kuzating. Tafsilotlar uchun asl manba havolasini oching.